vs
ChargePoint Holdings, Inc.（CHPT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
ChargePoint Holdings, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$105.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -49.7%，领先433.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 6.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -4.5%）
ChargePoint Holdings, Inc.是总部位于美国加利福尼亚州坎贝尔的电动汽车基础设施企业，运营着全球规模最大的独立所有电动汽车充电桩在线网络，站点覆盖14个国家，同时也自主研发生产相关充电技术设备。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CHPT vs RIGL — 直观对比
营收规模更大
CHPT
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出15.1%
6.1%
净利率更高
RIGL
高出433.7%
-49.7%
两年增速更快
RIGL
近两年复合增速
-4.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.7M | $69.8M |
| 净利润 | $-52.5M | $268.1M |
| 毛利率 | 30.7% | 91.5% |
| 营业利润率 | -42.0% | 33.2% |
| 净利率 | -49.7% | 384.0% |
| 营收同比 | 6.1% | 21.2% |
| 净利润同比 | 32.4% | 1769.2% |
| 每股收益（稀释后） | $-2.23 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHPTRIGL
| Q4 25 | $105.7M | $69.8M | ||
| Q3 25 | $98.6M | $69.5M | ||
| Q2 25 | $97.6M | $101.7M | ||
| Q1 25 | $101.9M | $53.3M | ||
| Q4 24 | $99.6M | $57.6M | ||
| Q3 24 | $108.5M | $55.3M | ||
| Q2 24 | $107.0M | $36.8M | ||
| Q1 24 | $115.8M | $29.5M |
净利润CHPTRIGL
| Q4 25 | $-52.5M | $268.1M | ||
| Q3 25 | $-66.2M | $27.9M | ||
| Q2 25 | $-57.1M | $59.6M | ||
| Q1 25 | $-58.8M | $11.4M | ||
| Q4 24 | $-77.6M | $14.3M | ||
| Q3 24 | $-68.9M | $12.4M | ||
| Q2 24 | $-71.8M | $-1.0M | ||
| Q1 24 | $-94.7M | $-8.2M |
毛利率CHPTRIGL
| Q4 25 | 30.7% | 91.5% | ||
| Q3 25 | 31.2% | 93.2% | ||
| Q2 25 | 28.7% | 95.6% | ||
| Q1 25 | 28.2% | 91.7% | ||
| Q4 24 | 22.9% | 89.9% | ||
| Q3 24 | 23.6% | 85.5% | ||
| Q2 24 | 22.1% | 92.4% | ||
| Q1 24 | 19.3% | 93.1% |
营业利润率CHPTRIGL
| Q4 25 | -42.0% | 33.2% | ||
| Q3 25 | -59.8% | 40.9% | ||
| Q2 25 | -55.1% | 60.1% | ||
| Q1 25 | -53.9% | 23.9% | ||
| Q4 24 | -68.4% | 28.9% | ||
| Q3 24 | -57.8% | 25.4% | ||
| Q2 24 | -62.7% | 1.2% | ||
| Q1 24 | -80.2% | -23.6% |
净利率CHPTRIGL
| Q4 25 | -49.7% | 384.0% | ||
| Q3 25 | -67.1% | 40.2% | ||
| Q2 25 | -58.5% | 58.6% | ||
| Q1 25 | -57.7% | 21.5% | ||
| Q4 24 | -77.9% | 24.9% | ||
| Q3 24 | -63.5% | 22.5% | ||
| Q2 24 | -67.1% | -2.8% | ||
| Q1 24 | -81.8% | -27.9% |
每股收益（稀释后）CHPTRIGL
| Q4 25 | $-2.23 | $14.11 | ||
| Q3 25 | $-2.85 | $1.46 | ||
| Q2 25 | $-0.12 | $3.28 | ||
| Q1 25 | $-5.83 | $0.63 | ||
| Q4 24 | $-3.56 | $0.82 | ||
| Q3 24 | $-3.22 | $0.70 | ||
| Q2 24 | $-0.17 | $-0.06 | ||
| Q1 24 | $-23.36 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $38.4M | $391.5M |
| 总资产 | $848.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CHPTRIGL
| Q4 25 | $180.5M | $155.0M | ||
| Q3 25 | $194.1M | $137.1M | ||
| Q2 25 | $195.9M | $108.4M | ||
| Q1 25 | $224.6M | $77.1M | ||
| Q4 24 | $219.4M | $77.3M | ||
| Q3 24 | $243.3M | $61.1M | ||
| Q2 24 | $261.9M | $49.1M | ||
| Q1 24 | $327.4M | $49.5M |
总债务CHPTRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CHPTRIGL
| Q4 25 | $38.4M | $391.5M | ||
| Q3 25 | $70.7M | $117.6M | ||
| Q2 25 | $118.6M | $81.9M | ||
| Q1 25 | $137.5M | $18.6M | ||
| Q4 24 | $181.0M | $3.3M | ||
| Q3 24 | $230.9M | $-14.6M | ||
| Q2 24 | $277.9M | $-29.9M | ||
| Q1 24 | $327.7M | $-31.7M |
总资产CHPTRIGL
| Q4 25 | $848.0M | $513.6M | ||
| Q3 25 | $870.3M | $242.5M | ||
| Q2 25 | $897.6M | $206.7M | ||
| Q1 25 | $898.2M | $176.0M | ||
| Q4 24 | $966.3M | $164.0M | ||
| Q3 24 | $1.0B | $139.4M | ||
| Q2 24 | $1.1B | $128.4M | ||
| Q1 24 | $1.1B | $126.5M |
负债/权益比CHPTRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.6M | — |
| 自由现金流率自由现金流/营收 | -22.3% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-69.6M | — |
8季度趋势，按日历期对齐
经营现金流CHPTRIGL
| Q4 25 | $-22.5M | $22.0M | ||
| Q3 25 | $-6.2M | $24.0M | ||
| Q2 25 | $-33.0M | $30.5M | ||
| Q1 25 | $-2.7M | $-893.0K | ||
| Q4 24 | $-30.6M | $14.5M | ||
| Q3 24 | $-51.2M | $21.7M | ||
| Q2 24 | $-62.5M | $302.0K | ||
| Q1 24 | $-41.5M | $-5.0M |
自由现金流CHPTRIGL
| Q4 25 | $-23.6M | — | ||
| Q3 25 | $-7.5M | — | ||
| Q2 25 | $-34.0M | — | ||
| Q1 25 | $-4.6M | — | ||
| Q4 24 | $-33.4M | — | ||
| Q3 24 | $-55.0M | — | ||
| Q2 24 | $-66.0M | — | ||
| Q1 24 | $-46.2M | — |
自由现金流率CHPTRIGL
| Q4 25 | -22.3% | — | ||
| Q3 25 | -7.6% | — | ||
| Q2 25 | -34.9% | — | ||
| Q1 25 | -4.5% | — | ||
| Q4 24 | -33.5% | — | ||
| Q3 24 | -50.7% | — | ||
| Q2 24 | -61.7% | — | ||
| Q1 24 | -39.9% | — |
资本支出强度CHPTRIGL
| Q4 25 | 1.0% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 4.1% | — |
现金转化率CHPTRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHPT
| Products | $56.4M | 53% |
| License And Service | $42.0M | 40% |
| Other | $7.3M | 7% |
RIGL
暂无分部数据
